Calendar Cumberland Pharmaceuticals Inc.

Equities

Market Closed - Nasdaq Other stock markets 16:30:00 2024-04-26 EDT			5-day change	1st Jan Change
1.76 ^USD	+3.53%		+10.00%	-1.77%

03-13	Tranche Update on Cumberland Pharmaceuticals Inc.'s Equity Buyback Plan announced on May 13, 2010.	CI
03-05	Cumberland Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

dc5aa24bae1.aj7TW8QWDGI_QikldCfa4bW0Fk2e-touNt8GkBbqCx0.PGaYD5NbbS5tCktSBkWsp9zHTyHqvIhFboBP0mezYE4eCqttrHtaLXkuGQ~6b1eb0ee2585719e7dc048a3d38cae83

2024-05-06	Q1 2024 Earnings Release (Projected)
2024-08-05	Q2 2024 Earnings Release (Projected)
2024-11-04	Q3 2024 Earnings Release (Projected)
2025-03-10	Q4 2024 Earnings Release (Projected)

2024-04-22	Annual General Meeting
2024-03-05 16:30	Q4 2023 Earnings Call
2024-03-05 16:05	Q4 2023 Earnings Release
2023-11-07 16:30	Q3 2023 Earnings Call
2023-11-07 16:05	Q3 2023 Earnings Release
2023-08-08 16:30	Q2 2023 Earnings Call
2023-08-08 16:05	Q2 2023 Earnings Release
2023-05-09 16:30	Q1 2023 Earnings Call
2023-05-09 16:05	Q1 2023 Earnings Release
2023-04-25 10:30	Annual General Meeting
2023-03-07 16:30	Q4 2022 Earnings Call
2023-03-07 16:23	Q4 2022 Earnings Release
2022-11-08 16:30	Q3 2022 Earnings Call
2022-11-07	Q3 2022 Earnings Release After hours
2022-08-09 16:30	Interim 2022 Earnings Call
2022-08-09 16:05	Interim 2022 Earnings Release
2022-05-10 16:30	Q1 2022 Earnings Call
2022-05-10 16:05	Q1 2022 Earnings Release
2022-04-28 10:30	Annual General Meeting
2022-03-08 16:30	FY 2021 Earnings Call

Fiscal Period	December	2019	2020
Net sales Million USD	Released Forecast Spread	47,5 45,2 5.17%	37,4 37,0 1.19%
EBITDA Million USD	Released Forecast Spread	4,98 3,65 36.5%	-0,07 -0,39 82.62%
EBIT Million USD	Released Forecast Spread	-3,62 -4,89 25.92%	-6,38 -6,31 -1.18%
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-3,63 -4,88 25.65%	-6,57 -6,53 -0.66%
Net income Million USD	Released Forecast Spread	-3,54 -4,79 26.2%	-3,34 -3,42 2.47%
EPS USD	Released Forecast Spread	-0,23 -0,31 25.81%	-0,22 -0,22 0%
Announcement Date		18/03/20	09/03/21

2024-04-28	CHONGQING PHARSCIN PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
2024-04-28	SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.: Q1 2024 Earnings Release
2024-04-29	SINOTHERAPEUTICS INC.: Q4 2023 Earnings Release
2024-04-29	KUNMING LONGJIN PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-29	OTSUKA HOLDINGS CO., LTD.: Q1 2024 Earnings Release
2024-04-29	YIFAN PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
2024-04-29	HANMI PHARM. CO., LTD.: Q1 2024 Earnings Release
2024-05-01	AJANTA PHARMA LIMITED: Q4 2024 Earnings Release (Projected)
2024-05-01	PROCTER & GAMBLE HEALTH LIMITED: Q3 2024 Earnings Release (Projected)
2024-05-06	SANDOZ GROUP AG: Q1 2024 Sales and Revenue Release

Today	HYBIO PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
Today	APICHOPE PHARMACEUTICAL CO., LTD: Q1 2024 Earnings Release
Today	YANTAI DONGCHENG PHARMACEUTICAL GROUP CO.,LTD.: Q1 2024 Earnings Release
Today	HARBIN GLORIA PHARMACEUTICALS CO., LTD: Q1 2024 Earnings Release
Today	SHANGHAI HAIXIN GROUP CO., LTD.: Q1 2024 Earnings Release
Today	ZHEJIANG CONBA PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
Today	YANTAI DONGCHENG PHARMACEUTICAL GROUP CO.,LTD.: Q4 2023 Earnings Release
Today	HYBIO PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-25	SINOTHERAPEUTICS INC.: Q1 2024 Earnings Release (Projected)
2024-04-25	SICHUAN GOLDSTONE ASIA PHARMACEUTICAL INC.: Q1 2024 Earnings Release